We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Gene Test for Breast Cancer Decreases Cost of Care Nationwide

News   Apr 25, 2019 | Original story from Georgetown Lombardi Comprehensive Cancer Center

 
Gene Test for Breast Cancer Decreases Cost of Care Nationwide

Cancer prognostic tests such as Oncotype DX and MammaPrint appear to lower the cost of breast cancer care in the US. Such tests provide a score based on her tumor's molecular makeup that indicates when a woman can forgo expensive chemotherapy. Credit: Genomic Health.

 
 
 

RELATED ARTICLES

Gene Linked to Impaired Memory in Down Syndrome – A Potential Drug Target?

News

It may one day be possible to reverse abnormal embryonic brain development linked to Down syndrome (DS) and improve cognitive function by therapeutically targeting a key gene known as OLIG2 prenatally, suggests newly published findings.

READ MORE

Optimizing the Endosperm With Genetics to Improve Corn Quality

News

Researchers may be able to improve corn yields and nutritional value after discovering genetic regulators that synthesize starch and protein in the widely eaten grain, according to a Rutgers-led study.

READ MORE

Discovery of Novel Genes May Lead to New Therapies for Muscle Cancer

News

Scientists have uncovered a unique set of genes that play a role in muscle cellular gene expression and differentiation which could lead to new therapeutic targets to prevent the spread of muscle cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE